新航道

  每場雅思考試之后，新航道上海學(xué)校雅思頻道小編會第一時間分享每次雅思考試大作文范文及解析，希望對各位備考考生們有所幫助，對雅思寫作有所提高!本文是8月10日雅思大作文范文及解析：醫(yī)藥公司的主要職責(zé)是什么。

  2019年8月10日雅思大作文題目：醫(yī)藥公司的主要職責(zé)是掙錢，還是為貧窮國家研究新藥?

  Some people say that drug companies have the responsibility to spend money on researching medicine to help the poorer countries, while others think that the main responsibility of drug companies is making money. Discuss these two views and give your own opinion.

  解析&審題

  本題是近年來難得一見的新題。

  醫(yī)藥公司的職責(zé)是為貧窮地區(qū)人們提供藥物，還是主要應(yīng)該掙錢?如果正確理解了這個題目，我們會發(fā)現(xiàn)其實(shí)并不難回答。

  醫(yī)藥公司當(dāng)然首先得要掙錢，這樣它才能生存，才能發(fā)展，也才能投入新藥的研究。但在承認(rèn)這個前提的情況下，我們也還是要提出醫(yī)藥公司應(yīng)該盡到的社會責(zé)任，也就是為貧窮國家的人們提供更優(yōu)質(zhì)，更廉價的產(chǎn)品，而不是一味只為了掙錢。

  因此，對于這個題目，我們的觀點(diǎn)就是：醫(yī)藥公司應(yīng)該承擔(dān)為貧窮國家提供藥品的社會責(zé)任，但完成這個責(zé)任的前提是醫(yī)藥公司需要掙錢。

  以下看唐老師對以上內(nèi)容的具體表達(dá)。

  老師筆記

  01

  A key responsibility of the world’s rich countries is to increase the amount of aid provided to the poorer countries, particularly in the field of health. The question is: should drug companies be responsible for finding new medicine for these countries or should they mainly focus on making money?

  世界富國的一項(xiàng)關(guān)鍵責(zé)任是增加向較貧窮國家提供的援助，特別是在衛(wèi)生領(lǐng)域。問題是：制藥公司是否應(yīng)該擔(dān)負(fù)為這些國家找到新藥的責(zé)任，還是應(yīng)該把重點(diǎn)放在賺錢上?

  解析

  (1) 本段引出話題，然后直接設(shè)問。這種開頭方式的優(yōu)點(diǎn)是直截了當(dāng)。

  (2) Aid 援助

  (3) Particularly 尤其是

  (4) Focus on 聚焦于......

  02

  On the one hand, drug companies in the developed world are under the moral obligation to make their medicinal products available and affordable in the under-developed world so that the poorer people do not die unnecessarily. According to a global survey, an estimated 2 billion people cannot get the medicines they need, with millions in south Asia and sub-Saharan Africa dying each year from curable diseases for lack of adequate medical treatment. As a consequence, many pharmaceutical companies have come under harsh criticism over making drugs in order to make huge money only, without particularly being interested in relieving the poorer people of their misery.

  一方面，發(fā)達(dá)國家的制藥公司有道德上的義務(wù)，使其藥品在欠發(fā)達(dá)的世界中買得到，也買得起，從而避免貧窮的人不必要地死去。根據(jù)一項(xiàng)全球調(diào)查，估計有20億人得不到所需的藥品，南亞和撒哈拉以南非洲每年有數(shù)以百萬計的人因缺乏足夠的醫(yī)療死于可治愈的疾病。因此，許多制藥公司都受到了嚴(yán)厲的批評，因?yàn)樗麄冊焖帲粸榱速嵉骄揞~的錢，而不是特別感興趣于減輕窮人的痛苦。

  解析

  (1) 本段論述醫(yī)藥公司的確有責(zé)任幫助貧窮國家提供廉價的醫(yī)藥產(chǎn)品。

  (2) Under the moral obligation to do...有做......的道德上的義務(wù)

  (3) Affordable 買得起的

  (4) Curable disease 可治愈的疾病

  (5) For lack of 因?yàn)槿鄙?.....

  (6) Pharmaceutical companies 醫(yī)藥公司

  (7) Come under harsh criticism 受到嚴(yán)厲批評

  (8) Relieve sb. of... 減輕某人的......

  03

  On the other hand, the main responsibility of drug companies is making money. It is because running a drug company is an expensive and high-risk endeavor. If a pharmaceutical firm does not make a significant profit, it cannot survive, let alone spending more money researching medicine to help the poorer people in the under-developed world. Too much money spent on medicine for people in the poorer countries may mean drug companies’ lower revenues, which will in turn lead to less innovation in the future. This is probably why some of the world’s biggest drug companies have failed to do what they are supposed to do.

  另一方面，制藥公司的主要責(zé)任是賺錢。這是因?yàn)榻?jīng)營一家制藥公司是一項(xiàng)昂貴和高風(fēng)險的事情。如果一家制藥公司沒有豐厚的利潤，它是無法生存的，更不用說花更多的錢去研究醫(yī)藥來幫助欠發(fā)達(dá)世界的窮人了。在貧窮國家的藥物上花太多錢，可能意味著公司的收入減少，而這反過來又會導(dǎo)致未來的創(chuàng)新減少。這可能就是為什么世界上一些最大的制藥公司沒能做到他們理應(yīng)做到的事情的原因所在。

  解析

  (1) 本段論述為什么醫(yī)藥公司得首先掙錢：沒有利潤，公司無法生存，更無法幫助任何人。

  (2) Run a company 經(jīng)營一家公司

  (3) Endeavor 嘗試;努力

  (4) Let alone 更不用說

  (5) Revenue 收入

  (6) In turn 反過來

  (7) Innovation 革新

  04

  In conclusion, one important responsibility of a drug company is making drugs to cure diseases everywhere in the world, especially the poor countries; but in order to do that, a drug company will have to make profits in the first place, without which it can do nothing.

  總之，制藥公司的一項(xiàng)重要職責(zé)是生產(chǎn)藥品，在世界各地特別是在貧窮國家治療疾病;但要做到這一點(diǎn)，制藥公司首先得盈利，沒有利潤就什么也做不了。

  解析

  (1) 總結(jié)前文的主要觀點(diǎn)，并回答題目的問題：醫(yī)藥公司應(yīng)該幫助貧窮國家，但首先得賺取利潤。

  (2) In the first place 首先;第一位

  高分參考范文：

  A key responsibility of the world’s rich countries is to increase the amount of aid provided to the poorer countries, particularly in the field of health. The question is: should drug companies be responsible for finding new medicine for these countries or should they mainly focus on making money?

  On the one hand, drug companies in the developed world are under the moral obligation to make their medicinal products available and affordable in the under-developed world so that the poorer people do not die unnecessarily. According to a global survey, an estimated 2 billion people cannot get the medicines they need, with millions in south Asia and sub-Saharan Africa dying each year from curable diseases for lack of adequate medical treatment. As a consequence, many pharmaceutical companies have come under harsh criticism over making drugs in order to make huge money only, without particularly being interested in relieving the poorer people of their misery.

  On the other hand, the main responsibility of drug companies is making money. It is because running a drug company is an expensive and high-risk endeavor. If a pharmaceutical firm does not make a significant profit, it cannot survive, let alone spending more money researching medicine to help the poorer people in the under-developed world. Too much money spent on medicine for people in the poorer countries may mean drug companies’ lower revenues, which will in turn lead to less innovation in the future. This is probably why some of the world’s biggest drug companies have failed to do what they are supposed to do.

  In conclusion, one important responsibility of a drug company is making drugs to cure diseases everywhere in the world, especially the poor countries; but in order to do that, a drug company will have to make profits in the first place, without which it can do nothing.

  (311 words)

  建議背誦的句子

  1. On the one hand, drug companies in the developed world are under the moral obligation to make their medicinal products available and affordable in the under-developed world so that the poorer people do not die unnecessarily.

  一方面，發(fā)達(dá)國家的制藥公司有道德上的義務(wù)，使其藥品在欠發(fā)達(dá)的世界中買得到，也買得起，從而避免貧窮的人不必要地死去。

  2. According to a global survey, an estimated 2 billion people cannot get the medicines they need, with millions in south Asia and sub-Saharan Africa dying each year from curable diseases for lack of adequate medical treatment.

  根據(jù)一項(xiàng)全球調(diào)查，估計有20億人得不到所需的藥品，南亞和撒哈拉以南非洲每年有數(shù)以百萬計的人因缺乏足夠的醫(yī)療死于可治愈的疾病。

  3. If a pharmaceutical firm does not make a significant profit, it cannot survive, let alone spending more money researching medicine to help the poorer people in the under-developed world.

  如果一家制藥公司沒有豐厚的利潤，它是無法生存的，更不用說花更多的錢去研究醫(yī)藥來幫助欠發(fā)達(dá)世界的窮人了。

  4. Too much money spent on medicine for people in the poorer countries may mean drug companies’ lower revenues, which will in turn lead to less innovation in the future.

  在貧窮國家的藥物上花太多錢，可能意味著公司的收入減少，而這反過來又會導(dǎo)致未來的創(chuàng)新減少。